Data / Form D filings / Strand Therapeutics Inc.
Strand Therapeutics Inc.: Form D filings
Strand Therapeutics Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2019 and 2026. The latest, on March 17, 2026, reports $108.1 million sold of a $120.1 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 Overland Street Suite A, Boston, MA, 02215
- Phone
- (617) 993-9271
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1778475
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | New notice | $120,099,940 | $108,099,927 | $12,000,013 | 10 | May 23, 2025 | sec.gov |
| Jul 27, 2021 | New notice | $52,143,967 | $52,143,967 | 13 | May 28, 2021 | sec.gov | |
| Jun 7, 2019 | New notice | $5,886,624 | $5,886,624 | 11 | May 24, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jacob Becraft | Executive Officer, Director, Promoter | |
| Tasuku Kitada | Executive Officer, Director, Promoter | |
| Ala Alenazi | Director | |
| Pegah Ebrahimi | Director | |
| Jory Bell | Director | |
| Jeb Keiper | Director | |
| Samta Kundu | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Mar 16, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Strand Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.